|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 USD | -2.03% |
|
+9.85% | -44.66% |
| Apr. 05 | Archon Capital Management Engages with Apyx Medical Corporation | CI |
| Apr. 01 | Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation | CI |
Apyx Medical Corporation reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 14.66 million compared to USD 12.61 million a year ago. Net loss was USD 9.61 million compared to USD 6.05 million a year ago.
Basic loss per share from continuing operations was USD 0.28 compared to USD 0.17 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.66% | 50.23M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
APYX MEDICAL CORPORATION 
